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Antecedents to Buyer-Supplier Coordination in the Pharmaceutical Supply Chain 
 
Abstract 
 
Purpose – The primary purpose of this study is to understand the antecedents that influence 
supply chain coordination in the pharmaceutical supply chain using the transaction cost analysis 
framework.  
 
Design/methodology/approach – Data from 156 retail pharmacies on their relationship with the 
pharmaceutical wholesalers are used to test the hypotheses.  
 
Findings – The findings of this paper show the importance of antecedents that are based on the 
transactional cost theory, such as asset specificity and environmental uncertainty. These 
antecedents impact the supply chain process coordination at different levels—transactional, 
operational and strategic.  
 
Research limitations/implications – Future research may investigate additional antecedents 
using other theoretical lenses. 
 
Practical implications – Pharmaceutical wholesalers are dependent on pharmaceutical 
manufacturers for the supply of products and face intense competition that results in lower profit 
margins. They also face a constant threat from the manufacturers, who could potentially bypass 
the wholesalers (disintermediation) and go direct to the pharmacies. To counterbalance the 
dependence, the wholesalers strive to achieve loyalty with the retail pharmacies. Through supply 
chain coordination, the wholesalers achieve efficiency in procurement for the pharmacies, thus 
reducing cost and improving their competitive advantage. 
 
Originality/value – This paper contributes to the supply chain coordination stream of literature.  
The three levels of process coordination are developed in this pharmaceutical supply chain 
context for the first time. The paper shows how process coordination can be achieved between 
the dyad without vertical integration.  
 
Keywords: Pharmaceuticals, Supply Chain, Process, Coordination. 
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Introduction 
 
 Effective management of pharmaceutical supply chain systems is becoming important in 
the current regulatory and business healthcare environment. In the past, production and distribution 
of products and information through the marketplace was considered of secondary importance in 
comparison to the much more critical strategies of managing revenue and profitability. Supply 
chain issues are becoming popular in the current literature as they directly address the fundamental 
concerns of today's pharmaceutical companies—the problems of drug safety, security, visibility, 
risk management, cost control, profitability and growth. In today's environment as firms 
experience competitive pressures to reduce product and operating costs, to deliver them faster, be 
more responsive to customer needs and to develop business processes to respond to the radical 
shifts in the marketplace requirements, they have been increasingly turning to the strengths to be 
found in their supply chain partners to enrich their competitive capabilities (Prajogo, Oke and 
Olhager 2016). 
 
In contemporary competitive and turbulent environment, the key to managing the supply 
chain is not managing different functions or products but managing the supply chain processes 
(Davenport 1993, Croxton et.al. 2001). Firms are aligning with their supply chain partners and 
creating business processes that are coordinated to gain competitive advantage in the marketplace. 
Supply chain coordination (a.k.a. integration) is defined as the extent to which the processes 
performed by the members of a distribution channel for a product or service are synchronized or 
matched.  To be responsive to the market place, firms should coordinate well laid-out processes to 
improve performance. Lack of quick response to the needs of the customers or environmental 
changes can create inefficiency that can prove to be extremely costly for firms. As a source of 
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competitive advantage, supply chain coordination may determine who will succeed or fail in the 
21st century.  
 Traditionally, the grocery industry, like most other industries, organized their people and 
managed their activities around business functions. The industry increasingly recognized that 
functional excellence did not translate to business excellence, which is achieved through superior 
business coordination. To achieve business excellence, firms should manage business processes 
and not the functions. Thus “Efficient Consumer Response” was an initiative in the grocery 
industry to improve firms’ competitive advantages. They strove for process integration to make 
the supply chain efficient, then automated the processes at much lower costs to further reduce 
wasted time and costs (Reyes and Bhutta 2005).  
In response to the emerging importance of process coordination between firms, we 
investigated the extent to which buyers (retail pharmacies) view themselves as integrated with 
their suppliers (i.e., wholesalers). Distribution of prescription drugs plays an important role in the 
delivery of healthcare. One of the goals of this distribution channel is to assure a continual flow of 
drugs to the patient, at optimal price, with minimal delays, few shortages, and with little room for 
error. The distribution system for prescription drugs is a dynamic, highly regulated, high 
performance system. Pharmaceutical supply chain must accommodate the infusion of an 
increasing number of new and expensive drugs to the marketplace while maintaining stringent 
security requirements, storage conditions and transportation requirements, especially the 
biotechnology products. Over the years, several regulations have been passed that have elevated 
the importance of the supply chain. For example, the Pharmaceutical Marketing Act of 1987 
requires the supply chain members to be licensed and to account for the drugs that are distributed 
through the system. In 1970, enactment of Control Substance Act required stringent monitoring of 
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the supply chain for scheduled drugs. In 2013, the United States Congress enacted the Drug Quality 
and Security Act to build a system to identify and track prescription drugs that are distributed in 
the United States so as to prevent counterfeit drugs in the supply chain and protect the consumers. 
Tracking and tracing the prescription drug all through the supply chain can also help to identify 
and remove drugs that are recalled by the manufacturer. Process coordination in the drug 
distribution system would ensure quick response, reduce costs, increase security and improve 
quality of the healthcare delivery system.  
The primary purpose of this study is to understand the factors that influence supply chain 
coordination in creating superior value in the supplier-pharmacy context. To identify influential 
determinants of supply chain coordination, we used the transaction cost analysis (TCA) 
framework. The major objectives of the study are to: (1) develop a model of supply chain 
coordination in a dyadic relationship and build the study hypotheses, (2) empirically test the study 
hypotheses, and (3) draw theoretical implications for future theory development and practical 
implications for pharmaceutical firms.  In the next two sections below, we develop and present our 
model and hypotheses grounded in the literature from multiple disciplines—marketing, operations, 
and logistics. Specifically, we use the Transaction Cost Theory to develop the hypotheses. We then 
present the empirical methodology used to collect and analyze data from a random sample of 
pharmacies in the U.S. Next, we present the results and finally draw implications for managers 
and researchers. Identifying the influential factors in the model should enable the channel members 
to manage the channel better, thus improving the quality of distribution and eventually quality of 
care to the patients.  
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Supply Chain Process Coordination 
Is supply chain process coordination the same as supply chain management? Supply chain 
management is defined as a continuously evolving management philosophy. It encompasses the 
management of upstream and downstream relationships with suppliers and buyers to deliver 
superior customer value at a lesser cost to the supply chain (Ledlow et.al. 2017). It seeks to unify 
the collective productive competencies and resources of the business processes found both within 
the firm and outside in the firm’s allied business partners. It pools various supply chain partners 
located along intersecting supply channels into a highly competitive, customer-enriching supply 
system. Such a system is focused on developing innovative solutions and synchronizing the flow 
of marketplace products, services, and information to create unique, individualized sources of 
customer value (Siyu et.al. 2018). Supply chain process coordination, on the other hand, is a 
comprehensive, strategic, objective-oriented, process-based approach of coordinating various 
interorganizational processes. Process coordination is done to more efficiently and effectively 
meet customer requirements and to create a competitive advantage in the market place by 
competing as a total system (Prajogo, Oke and Olhager 2016).  
In definitional terms, a process is simply a structured, measured set of activities designed 
to produce a specified output for a particular customer or market. It implies a strong emphasis on 
how work is done within or between organizations, in contrast to a product focus—emphasis on 
what the focal product processes are (Davenport 1993). A process is thus a specified ordering of 
work activities across time and place, with a structure for action. In the supply chain context, 
processes within or between organizations should be coordinated such that superior business 
performance can be achieved (Mehralian et al. 2015, Lambert 2008). In a recent study published 
on top 10 issues in the healthcare supply chain, the number one issue is “coordination” in the 
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supply chain (Privett and Gonsalvez 2014). This underscores the importance of supply chain 
coordination, the focus of our paper.  
There have been many literature reviews published on the topic of supply chain 
coordination and some recent ones in chronological order include Dixit et al. 2019; Srivastava 
2017; Narayana et al. 2014; Leushner et al. 2013; Chen, Daugherty & Roath 2009; Fabbe-Costes 
& Jahre 2008; Van der Vaart & van Donk 2008). Unlike extant literature, we conceptualized 
supply chain coordination as a process matching mechanism that can occur at three levels (See 
Figure 1). First, the buyers and suppliers can coordinate their transaction processes to reduce or 
mitigate errors, improve cycle time, and avoid duplication of efforts. The product ordering process, 
fulfillment process, billing and payment processes, and the returned goods processing are 
examples of transaction processes. Invariably, transactional coordination is considered a basic 
requirement in supply chain relationships.  
****************************** 
Insert Figure 1 Here 
****************************** 
 At the next level, supply chain coordination of the operational processes between a buyer 
and a supplier takes place. Examples of such processes are the employee training process, financial 
management process, inventory management process, and information systems management 
process. The coordination of operational level processes eliminates duplication of inventory 
stockpiles and improves future planning due to enhanced transparency. Since the needs of the 
customers vary and the levels of resources available to different suppliers vary, homogenous 
implementation of operational coordination is highly inefficient.  Therefore, most firms first will 
focus on their most important partners or will respond to the ones that show inclination for process 
coordination. This can lead to variability in the performance of the supply chain. 
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 When two firms link higher level processes that are crucial for the strategic success of both 
firms, then it is termed as strategic coordination. Such firms take a comprehensive view of their 
supply chain and focus on jointly producing superior value for their end-customer. Invariably, 
higher level decision-makers from both organizations are involved to spur such coordination 
efforts.  It primarily has a long-term focus with an ongoing planning effort. In a pharmaceutical 
setting, it spans various processes such as advertising and promotions planning, back-to-school 
sale planning, marketing, prime vendor programs, retail employee training programs, technology 
needs assessment, etc. Strategic coordination can form the core of winning supply chains (Kearney 
1995). 
    This study addresses the following research question: What factors lead to supply chain 
process coordination? These factors are also called the antecedents to supply chain process 
coordination.  
  
Key Drivers of Supply Chain Process Coordination 
What motivates our buyer-supplier dyad to coordinate its supply chain processes? In 
general, we contend that it is the motivation of the dyad to limit or minimize the transaction costs 
of their exchange. Transaction costs are essentially the costs associated with performing tasks 
such as gathering information, negotiating, monitoring performance, etc. We identify below the 
factors that mark these exchange conditions and, in turn, drive the dyad to engage in supply 
chain process coordination at all levels of the organization—transactional, operational and 
strategic (See Figure 1).  
 
Transaction Cost Theory 
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The transaction cost theory proposes that when a transaction is more efficiently 
performed within a firm (i.e., vertical integration) or outside it, as opposed to autonomous 
contractors (i.e., market governance). The theory assumes that humans as transactors have 
“bounded rationality” (limited foresight into the future), and they are “opportunistic” and “risk 
neutral.”  As per the transaction cost theory, transactions are more efficient under “market 
governance” where competition drives the market, and price becomes the determining factor for 
efficiency. When certain dimensions of transactions raise the transaction costs, thus creating 
market failure, then there can be alternative forms of governance that can create efficiency in the 
transactions and safeguard the investment in the transactions. Such forms of governance may be 
hierarchical (vertical integration), where the ownership provides explicit contractual safeguards 
to protect against transaction hazards (Poppo & Zenger 2002), or relational, where collaborative 
exchanges (alliance) take place via coordination (Dyer 1997). The latter may be a viable 
alternative to hierarchy when the market fails. The dimensions that raise the transaction costs are 
asset specificity, uncertainty and transaction frequency (Williamson 1985). In this study, 
hypotheses are developed to test how the transaction cost dimensions (asset specificity and 
uncertainty) influence relational governance by supply chain coordination (alliance).  
 
Asset Specificity 
Asset specificity implies assets that are unique and tailored to a particular transaction and 
cannot be easily redeployed to another relationship apart from the parties involved in the 
transaction. These idiosyncratic assets raise a safeguarding problem because of the possibility of 
opportunistic exploitation of one-party demanding concessions, when the market governance of 
competition does not work. The solution provided by the transaction cost theory is vertical 
integration or hierarchical governance of a single ownership. Vertical integration via ownership 
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can increase control and safeguard the investment, but it increases the cost to the buyer 
significantly and does not completely protect against transaction hazards (Poppo & Zenger 
2002). Also, the cost to dissolve the integration is very high. In order to safeguard the 
investment, firms can utilize relational governance via coordination of processes without 
significant cost of ownership.  
 
Thus: 
 H1a: Asset specificity is positively related to transactional process coordination. 
H1b: Asset specificity is positively related to operational process coordination. 
H1c: Asset specificity is positively related to strategic process coordination. 
Environmental Uncertainty 
The second dimension, uncertainty, arises either when the relevant contingencies 
surrounding an exchange are too unpredictable to be specified ex ante in a contract 
(environmental uncertainty) or performance cannot be easily verified ex post (behavioral 
uncertainty). Environmental uncertainty refers to “unanticipated changes in circumstances 
surrounding an exchange” (Noordewier, John and Nevin 1990, p. 82). The primary consequence 
of environmental uncertainty is an adaption problem, that is adjusting agreements raises 
transaction costs, problem that can be addressed through vertical integration. One can, however, 
argue that high environmental uncertainty also encourages firms to maintain flexibility, which 
would go against vertical integration.  
Environmental uncertainty can be operationalized as ‘unpredictable nature of the external 
environment.’ Klein suggested that ‘uncertainty is too broad a concept and that different facets of 
it led to both desire for flexibility and a motivation to reduce transaction costs’ (1989; 256). We 
have adopted the dimensions of environmental uncertainty of “volatility (dynamism) and 
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diversity (complexity)” in the environment as proposed by Klein and his colleagues (Klein 1989; 
Klein, Frazier and Roth 1990). The constructs of dynamism and complexity might have opposite 
effect on the extent of coordination between the parties. Klein and his colleagues posit that while 
dynamism encourages firms to form higher levels of integration (requiring higher coordination), 
complexity has just the opposite effect. Under conditions of complex environments in alliances, 
adaptations cannot be made unilaterally because they require mutual consent from both parties. 
Building such consent may take time and may be in a short supply in uncertain environments. 
Thus, the dynamism aspect of environmental uncertainty is defined as the rate of change in the 
environment and the complexity aspect as the degree to which the environment is heterogenous 
due to multiple sources of uncertainty in the environment ().  
Thus, 
H2a: Environmental dynamism is positively related to transactional process coordination  
H2b: Environmental dynamism is positively related to operational process coordination 
H2c: Environmental dynamism is positively related to strategic process coordination 
H3a: Environmental complexity is negatively related to transactional process 
coordination 
H3b: Environmental complexity is negatively related to operational process coordination 
H3c: Environmental complexity is negatively related to strategic process coordination 
 
Behavioral Uncertainty 
Behavioral uncertainty is a performance evaluation problem, that is difficulty of observing 
and measuring compliance of the transacting parties to the contractual agreement. According to 
the transaction cost theory, the general response to the performance evaluation problem is vertical 
integration and Anderson (1985). In channel conditions, where vertical integration does not exist, 
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does difficulty in performance assessment increase the likelihood of supply chain process 
integration? The transaction cost theory suggests under conditions of higher behavioral 
uncertainty, higher levels of process coordination may be able to reduce the evaluation problems 
of the supplier. Thus: 
H4a:  Behavioral Uncertainty is positively related to transactional process coordination 
H4b:  Behavioral Uncertainty is positively related to operational process coordination 
H4c:  Behavioral Uncertainty is positively related to strategic process coordination 
 
Data Collection and Analysis 
This study is based on a cross-sectional survey of pharmacies in USA. We chose the survey 
methodology over conducting case studies of some dyads because we wanted a greater 
generalizability of the results.  Given the nature of the study variables, we could not conceive of a 
field or lab experiment.  
The list of pharmacies was obtained from each state department of licensing and regulation. 
Six hundred potential respondents were solicited through phone calls first.  The mail survey was 
filled out by a pharmacy representative who was involved in the purchasing activities and had 
knowledge about the nature of the relationship with their wholesaler. The benefits of this study 
were enumerated in the cover letter to motivate the respondents and included a report of the study 
to those who provided their address. We followed up with a post card reminder. The respondents 
were asked to evaluate one of their suppliers.  
 To operationalize constructs of the study, we used both reflective and formative scales. 
Supply chain process coordination is measured using a formative scale and all other constructs 
with reflective scales. The convergent validity and discriminant validity were assessed by 
examining the correlations between constructs. Convergent validity was supported as the factors 
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facilitating supply chain process coordination and other control measures correlated appreciably 
with the outcome measures.  There is evidence for discriminant validity as the three antecedents 
do not correlate significantly with one another and other measures that are not hypothesized to 
correlate.  The nonresponse bias was ruled out as the T-tests between early and late respondents 
indicated no significant differences on the measures of interest. 
 The scale reliability was checked using the Cronbach’s alpha for reflective scales, which 
were all above 0.70 as shown in Table 1. The factor analyses, presented in Table 2, also validated 
the composition of the scales as the items loaded on the desired factor. Similarly, a Cohen index 
was calculated for the formative scales. The Cohen Index is similar to Cronbach’s Alpha, which 
is used for reflective scales. Before conducting the regression analyses to test the hypotheses, 
multicollinearity problems were checked. The correlations of each of the independent variable in 
the regressions with all the other independent variables was used to assess multicollinearity. The 
means, standard deviations of the scales, and the correlations were created and evaluated. 
****************************** 
Insert Table 1 and Table 2 Here 
****************************** 
 
The Ordinary Least Square Regressions were conducted to test the study hypotheses about 
relationships between the antecedents and supply chain process coordination index.  Age of the 
relationship, channel volume and whether the contract was written or not were used as control 
variables. The regression equations are shown below: 
Each type of process coordination = f (asset specificity, environmental dynamism, environmental 
complexity, behavioral uncertainty, written contract, 
channel volume and age of relationship) 
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For all the multi-item constructs, the summated scores were used in the regression analyses.  
Adjusted R-square was used to estimate the explained variance of the model.  
 
Results 
 All three regression models, one for each type of process coordination, were significant at 
p<0.05. The R-squared for the three regressions range between 0.31-0.45, which means the control 
variables and study variables combined explain a significant amount of variance in each of the 
three dependent variables—the three types of process coordination. Of the three control variables, 
two—length of the relationship between a buyer and supplier and the presence of a written 
contract—are statistically significant in each of the three models. The third control variable, 
channel volume, is non-significant in all three models, which means that the extent of coordination, 
no matter what type, is not influenced by the volume of transactions in a dyadic relationship. This 
was an unexpected finding and needs to be explored further. 
 
 Hypotheses H1a-H1c are supported as asset specificity is significantly and positively (p-
values ranging between 0.01 and 0.012) related to the three types of process coordination—
transactional, operational and strategic coordination—as shown in Tables 3 through 5. Hypotheses 
H2b and H2c are also supported as environmental dynamism is negatively and significantly related 
to the operational (p=0.058) and strategic process integration (p =0.035). H2a is, however, not 
supported. Environmental complexity and behavioral uncertainty are positively related to only 
transactional process integration at p =0.04 and p =0.01 respectively, but not to either the 
operational or strategic process integration. Hence H3a and H4a are supported, but H3b-H3c and 
H4b-H4c are not supported. The results are discussed below. 
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****************************** 
Insert Tables 3, 4 and 5 Here 
****************************** 
 
Discussion 
The results of the study support the transaction cost theory’s predication that asset 
specificity motivates supply chain process coordination significantly across all three levels—
transactional, operational and strategic. This is a significant finding of the study. With higher levels 
of supply chain coordination, the wholesaler and the pharmacy might be able to safeguard their 
idiosyncratic investments and potentially reduce transaction costs. In the past, transaction cost 
theory was applied to vertical integration (common ownership). It is important to note that the 
transaction cost theory can be applied even in cases of “virtual coordination” based on processes. 
Aligning supply chain processes can create efficient supply chain system and it can be as 
successful as vertical integration. 
Based on the extant literature, environmental dynamism was proposed to be positively 
related to supply chain coordination at transaction, operational and strategic levels. On the 
contrary, the results indicate that the impact is not-significant at the transaction level, but 
significant at the operational and strategic level though in the opposite direction of what was 
predicted. The results show that environmental dynamism is negatively related to coordination at 
the operational and strategic level. This indicates that the environmental dynamism does not have 
an impact on the day to day dealings that are routine and transactional, but it does impact negatively 
the coordination at the operational and strategic levels. In a rapidly changing environment, it might 
be challenging to coordinate activities given the pace of change because it takes time to plan and 
act in those situations. 
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Environmental complexity, on the other hand was predicted to be negatively related to 
supply chain coordination at all the three levels. We, however, found that environmental 
complexity was significant and positively correlated at the transaction level and not-significant at 
the operational and strategic levels. This finding illustrates that firms do coordinate when the 
environment is complex to reduce uncertainty and make adaptations to reduce transaction costs. 
Both environmental dynamism and complexity have different effects on supply chain coordination 
which is an intriguing finding. This study to some extent proves that these two environmental 
uncertainty constructs are unique and different dimensions of the environment and have opposing 
effects on coordination. Further work is necessary for theoretical development of the 
environmental uncertainty construct in the pharmaceutical supply chain context. 
Finally, behavioral uncertainty had a positive and significant impact on transactional 
coordination, but no significant effect on operational and strategic coordination. Behavioral 
uncertainty is a performance evaluation problem and it increases the transaction cost because of 
difficulty in ascertaining ex post contractual compliance between the wholesaler and the pharmacy. 
In this case, based on the transaction cost theory, the performance evaluation problem could be 
addressed by coordination. Also, performance evaluation is easier at the transaction level as 
opposed to the operational and strategic levels. In the pharmaceutical supply chain context, the 
transactions are highly automated using information technology and it is easy to monitor the day-
to-day transactions, both of which enhance coordination.  
In summary, the results in general support the transaction cost theory predications for asset 
specificity at all three levels (transactional, operational and strategic coordination). Environmental 
uncertainty (dynamism and complexity) are complicated findings and require further investigation. 
Behavioral uncertainty is found to impact the transactional level coordination. Even though the 
 17 
transaction cost theory is utilized in supply chain research in other industries, this is seminal 
research for the pharmaceutical supply chain context.  
 
Managerial Implications 
            In a recent study (Singh et al. 2016), the number one issue identified in the pharmaceutical 
supply chain is supply chain coordination, the topic of this paper. We studied the key transaction 
cost theory factors that influence coordination between the wholesalers and the pharmacies at the 
transactional, operational and strategic levels. The management at the wholesaler and pharmacies 
can improve coordination that will reduce transaction costs and improve performance. The 
wholesalers invest significantly in the relationship with the pharmacies by providing customized 
IT and other services to enable the pharmacies to succeed in their business. The pharmacies also 
buy most of their product requirements from one wholesaler and participate in the loyalty program 
offered by the wholesaler. With high levels of idiosyncratic investments, high levels of 
coordination and sharing information would safeguard investments and reduce transaction costs to 
both parties.  
 The results of this study show that environmental dynamism is negatively related to 
coordination at the operational and strategic levels. Rapidly changing (dynamic) environment 
creates a speculation about the future and coupled with bounded rationality of managers it may 
lead to guarded approach to coordination. On the other hand, a complex environment facilitates 
coordination leading to better adaptation at the transaction level. These constructs require further 
exploration and testing to understand their opposite impact on coordination. Researchers in the 
past have had significant challenges with these constructs and more studies need to be conducted 
to understand their role in the supply chain. Finally, behavioral uncertainty has a positive impact 
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on coordination at the transaction level. Coordination will enable better monitoring of the day to 
day operations, evaluate the performance of the other party, and improve the performance of the 
supply chain.   
The findings will help the wholesaler-pharmacy dyad in the pharmaceutical supply chain 
on the importance of supply chain coordination. The study clearly illustrates that coordination 
occurs at different levels (transactional, operational and strategic) and different transaction cost 
drivers have varied impact on coordination. Supply chain efficiency is very important in the 
pharmaceutical supply chain and this study shows that coordination across the supply chain can 
achieve those efficiencies. Supply chain coordination can achieve product availability to the 
patients at the right quality, right quantity, right time, right location and right price. Unlike other 
industries, the consequences of supply chain failure due to counterfeit drug infiltration, drug 
shortage, etc., can have dire impact on the healthcare system. In addition, the healthcare industry 
is highly regulated and so coordination among the supply chain members is critical for the safe 
and secure supply chain. To the best of our knowledge, this is the first empirical study to show the 
importance of supply chain coordination in the pharmaceutical supply chain with significant 
implications for wholesalers and pharmacies.  
 
Limitations and Directions for Future Research 
There are several limitations to this study, which should serve as a fertile ground for future 
research. First, this is a cross sectional study and thus precluded measurement of the dynamic 
nature of some of the constructs. Second, the perception of the relationship is observed only from 
the pharmacy’s point of view and not from the drug supplier’s perspective. Third, this study used 
a single informant, which is appropriate for half of our sample as for pharmacies that are smaller 
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in operation, such as the independents, these informants make the key purchasing decisions. Chain 
pharmacies in contrast might have multiple decision-makers in purchasing activities. Even though 
efforts were made to identify the key informant through a phone call, still it is possible that the 
survey respondents might not be fully aware of the decision-making situations and their 
pharmacy’s preferences in all situations.  
Fourth, the generalizability of study results may also be limited due to the following 
factors. The theory is tested in a pharmaceutical channel, which is somewhat unique due to the 
product, directed nature of the demand, and stringent regulation by the government.  Further, the 
changes in technology and third-party payer influences are important factors that may limit the 
generalizability of the findings over time.  Additionally, our sample is comprised of 50% 
independent pharmacies which may sway the findings a little.  The pharmacists who manage 
independent pharmacies often have limited management training. Thus, their perceptions and 
responses could be different from those who are more highly trained in management, thus 
confounding the results of the study. Fifth, this study tried to address all the key transaction cost 
theory-based constructs and their relationships in this context. However, there may be other 
constructs that are based on other theories, such as the resource dependence theory, social 
exchange theory and social network theory that could contribute to understanding this issue further 
but were not included inadvertently (Gligor et. al. 2019). Sixth, the coordination was 
conceptualized at three levels (transactional, operational and strategic). We did not investigate if 
one has to achieve coordination in a linear fashion, that is transactional coordination before 
operational and strategic. Also, we didn’t explore if one can achieve strategic coordination without 
transactional or operational coordination. Further studies are needed to examine these questions. 
Finally, one can study the consequences of supply chain coordination on responsiveness, 
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flexibility, risk management, compliance to regulations, etc. Despite the aforesaid limitations, this 
study provides valuable information from the practical standpoint of pharmacy professionals, 
contributes to the theory development by examining antecedents to process coordination based on 
the transaction cost analysis, and raises many questions for future research. 
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Appendix 
 
Asset Specificity (5)   α =0.85 
(1=Strongly Disagree to 7=Strongly Agree) 
1. We have significant investments in equipment dedicated to our relationship with this wholesaler. 
2. A lot of the tasks we perform in the procurement process require closely working with the wholesaler. 
3. Our procurement systems has been tailored to meet the transactions with this wholesaler. 
4. Most of the training our pharmacy staff has gone through is to learn the wholesalers’ procedures and 
routines. 
5. We have made extensive adjustments in our pharmacy in order to deal effectively with this wholesaler. 
 
Environmental Dynamism (5) α =0.88 
(Anchored 1=stable to 7=unstable) 
1. Stability of prescription sales volume 
2. Stability of local market trends 
3. Stability of market shares 
4. Stability of Pharmaceutical prices 
5. Stability of overall conditions of the local market 
 
Environmental Complexity (5) α =0.62  
(anchored 1=easy to 7=difficult ) 
1. Monitoring market trends 
2. Number of competitors in our market 
3. Assessing marketplace competition 
4. Managing third party contracts 
5. Market in which we buy pharmaceuticals 
 
Behavioral Uncertainty (4)  α =0.70 
(1=Strongly Disagree to 7=Strongly Agree) 
 
1. Assessing performance of the supplier is a complicated matter 
2. It is inadequate to evaluate this supplier based only on based on price 
3. Evaluating the performance of this supplier requires extensive inspection 
4. Conducting performance evaluations of this supplier requires making sure they follow agreed 
upon procedures. 
 
Please circle the extent of coordination between you and the wholesaler in the following 
processes. Circle the response that best represent the level of coordination between you and your 
wholesaler (1= minimal, 5 = extensive) 
 
Transactional (4)  
a. Product ordering process 
b. Product fulfillment process 
c. Billing and payment process 
d. Return goods process 
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Operational (6)  
e. Inventory management process 
f. Store financial management process 
g. Employee training process 
h. Information system management support 
i. Store layout/design support 
j. New service development process 
 
Strategic (7)  
k. Pricing process 
l. Promotional process 
m. Market research process 
n. Planning process to reduce costs 
o. Planning process to improve responsive to patients 
p. Information sharing process 
q. Contract administration process 
 
Channel Volume in percentage 
1. What percentage of your total annual dollar purchases of prescription drugs do you obtain 
from this particular supplier ? _____% 
 
Length of Relationship in years 
2. How long have you been doing business with this supplier ? _____Years 
 
Written Contract (Yes/No) 
3. Does your company have a written contract with the supplier (yes or no) 
 23 
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Figure 1: Levels of Supply Chain Coordination 
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TABLE 1. DESCRIPTIVE STATISTICS OF MEASURES 
 
Measure (Number of items)   Mean  Std. Dev. Reliability 
 
Asset Specificity (5)    19.38    7.16  0.85 
Environmental Dynamism (5)  15.60    5.82  0.88 
Environmental Complexity (5)  21.99    4.75  0.62 
Behavioral Uncertainty (4)   19.45    4.19  0.70 
Transactional Process Coordination (4) 13.19    4.52   Formative Scale 
Operational Process integration (6)  10.88    4.64   Formative Scale 
Strategic Process integration (7)  11.46    5.08   Formative Scale 
Channel Volume in percentage (1)  84.47  25.43   Single Item 
Length of Relationship in years (1)   9.46    9.75   Single Item 
Written Contract (Yes/No)     ---    ---   Single Item 
 
Pharmacy Type 
 Independent     50 (32.1%)  
 Small Pharmacy Chain (2-9 units)  24 (15.4%) 
 Large Pharmacy Chain (>10 units)  36 (23.1%) 
 Food-Drug Combination Chain  30 (19.2%) 
 Mass Merchandise Chain   16 (10.3%) 
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TABLE 2.   FACTOR ANALYSIS 
 
 
 1 2 3 4  
     
Asset Specificity1   .750     
Asset Specificity2   .840     
Asset Specificity3   .760     
Asset Specificity4   .796     
Asset Specificity5   .774     
Enviro Complexity1     .594   
Enviro Complexity2     .413   
Enviro Complexity3     .809   
Enviro Complexity4     .494   
Enviro Complexity5     .772   
Enviro Dynamism1 .906       
Enviro Dynamism2 .900       
Enviro Dynamism3 .878       
Enviro Dynamism4 .602       
Enviro Dynamism5 .701       
Behavioral Uncertainty1       .676  
Behavioral Uncertainty2       .658  
Behavioral Uncertainty3       .843  
Behavioral Uncertainty4       .627  
 
 
    
Extraction Method: Principal Component Analysis.   Rotation Method: Varimax with Kaiser Normalization. 
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TABLE 3.  REGRESSION RESULTS FOR TRANSACTIONAL PROCESS 
COORDINATION 
 
 
Independent Variable  Beta   T-Statistic  p-value 
 
Asset Specificity    0.39     3.86   <0.01*** 
Environmental Dynamism  -0.14   -1.26     0.21 
Environmental Complexity   0.22     2.02     0.04** 
Behavioral Uncertainty   0.27     2.60     0.01*** 
Length of Relationship   0.36     2.98     0.01*** 
Channel Volume    0.15     1.43     0.16 
Written Contract    0.20     1.85     0.07* 
 
 
Model:  Adjusted R2 = 0.38  F value = 5.86 (p < 0.001) 
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TABLE 4.  REGRESSION RESULTS FOR OPERATIONAL PROCESS 
COORDINATION 
 
Independent Variable  Beta   T-Statistic  p-value 
 
Asset Specificity     0.34     3.60   <0.01*** 
Environmental Dynamism  -0.20   -1.93   0.058* 
Environmental Complexity   0.03    0.25   0.802 
Behavioral Uncertainty  -0.07   -0.69   0.492 
Length of Relationship   0.50    4.87   <0.01*** 
Channel Volume    0.15    1.61   0.112 
Written Contract                                 0.20    1.75   0.076* 
 
 
Model:  Adjusted R2 = 0.45  F value = 7.70 (p < 0.01) 
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TABLE 5. REGRESSION RESULTS FOR STRATEGIC PROCESS COORDINATION 
 
 
Independent Variable  Beta   T-Statistic  p-value 
 
Asset Specificity    0.28    2.59   0.012** 
Environmental Dynamism  -0.25   -2.16   0.035** 
Environmental Complexity   0.15    1.29   0.201 
Behavioral Uncertainty  -0.10   -0.89   0.376 
Length of Relationship   0.39    3.40   0.001*** 
Channel Volume    0.16    1.47   0.145 
Written Contract    0.21    1.79   0.078* 
 
 
Model:  Adjusted R2 = 0.31  F value = 4.27 (p < 0.05) 
 
 
 
 
 
 
